Zobrazeno 1 - 10
of 90
pro vyhledávání: '"Safiya, Karim"'
Autor:
Said Hussein, Chloe Ahryung Lim, Thulasie Manokaran, Shireen Kassam, Madalene Earp, Patricia A. Tang, Safiya Karim, Patricia Biondo, Sharon M. Watanabe, Aynharan Sinnarajah, Amy Tan, Jessica Simon
Publikováno v:
Current Oncology, Vol 31, Iss 3, Pp 1235-1245 (2024)
(1) Background: This observational cohort study describes the frequency, content, and satisfaction with advance care planning (ACP) conversations with healthcare providers (HCPs), as reported by patients with advanced colorectal cancer. (2) Methods:
Externí odkaz:
https://doaj.org/article/a6869b8ddee94b7d977871d8402e3476
Autor:
Safiya Karim, Jennifer Lowther, Gabriel Gyulay, Dylan O’Sullivan, Christopher J. D. Wallis, Steven M. Yip, Darren R. Brenner, Devon J. Boyne, Winson Y. Cheung
Publikováno v:
Current Oncology, Vol 30, Iss 9, Pp 8149-8158 (2023)
Introduction: Over the past decade, the treatment of metastatic castration-sensitive prostate cancer (mCSPC) has changed significantly. Current guidelines suggest the use of androgen deprivation therapy (ADT) plus an additional systemic therapy, rega
Externí odkaz:
https://doaj.org/article/3d13741c0c444fc0ada6fdd1c670e619
Autor:
Marya Hussain, Chelsea Wong, Eddy Taguedong, Saurav Verma, Md Mahsin, Safiya Karim, Richard Lee-Ying, Doreen A. Ezeife
Publikováno v:
Current Oncology, Vol 30, Iss 8, Pp 7706-7712 (2023)
New oncology drugs undergo detailed review prior to public funding in a single-payer healthcare system. The aim of this study was to assess how cancer drug review times impact funding recommendations. Drugs reviewed by the pan-Canadian Oncology Drug
Externí odkaz:
https://doaj.org/article/ee66eb7f138d488db02a69eff1e5be2d
Publikováno v:
Current Oncology, Vol 29, Iss 7, Pp 5091-5096 (2022)
Globally, there is increasing emphasis on value-based cancer care. Rising healthcare costs and reduced health care spending and budgets, especially in low- and middle-income countries (LMICs), call for patients, providers, and healthcare systems to a
Externí odkaz:
https://doaj.org/article/1b7563f228374399b535fb1ad9be34a5
Autor:
Nicholas A. Bosma, Matthew T. Warkentin, Chun Loo Gan, Safiya Karim, Daniel Y.C. Heng, Darren R. Brenner, Richard M. Lee-Ying
Publikováno v:
European Urology Open Science, Vol 37, Iss , Pp 14-26 (2022)
Context: Considerable advances have been made in the first-line treatment of metastatic renal cell carcinoma (mRCC), with immunotherapy-based combinations including immunotherapy-tyrosine kinase inhibitors (IO-TKIs) and dual immunotherapy (IO-IO) fav
Externí odkaz:
https://doaj.org/article/c580ba678b22489b80abd48ba7373998
Publikováno v:
Current Oncology, Vol 29, Iss 3, Pp 1527-1536 (2022)
The Serious Illness Care Program (SICP), designed by Ariadne Labs, is a multicomponent intervention to improve conversations about values and goals for patients with a life-limiting illness. In oncology, implementation of the SICP achieved more, earl
Externí odkaz:
https://doaj.org/article/a49e8a4359b24833b110c64c9b57a3ed
Autor:
Ellen Cusano, Chelsea Wong, Eddy Taguedong, Marcus Vaska, Tasnima Abedin, Nancy Nixon, Safiya Karim, Patricia Tang, Daniel Y. C. Heng, Doreen Ezeife
Publikováno v:
Current Oncology, Vol 28, Iss 6, Pp 4894-4928 (2021)
In the era of rapid development of new, expensive cancer therapies, value frameworks have been developed to quantify clinical benefit (CB). We assessed the evolution of CB since the 2015 introduction of The American Society of Clinical Oncology and T
Externí odkaz:
https://doaj.org/article/e8bdd00222fe45b39718365154b929ed
Publikováno v:
Integrative Cancer Therapies, Vol 21 (2022)
Integrative Oncology (IO) programs are increasingly emerging at cancer centers and universities worldwide; often these include some combination of clinical service, research, and/or training. However, one gap that often occurs is in moving research r
Externí odkaz:
https://doaj.org/article/b7280b6c975040c0b966a3e4081fc8df
Autor:
Safiya Karim, Rita Benn, Linda E. Carlson, Judith Fouladbakhsh, Heather Greenlee, Rick Harris, N. Lynn Henry, Shruti Jolly, Sabrina Mayhew, Lisa Spratke, Eleanor M. Walker, Bradley Zebrack, Suzanna M. Zick
Publikováno v:
Current Oncology, Vol 28, Iss 1, Pp 853-862 (2021)
A growing number of cancer patients use complementary and alternative therapies during and after conventional cancer treatment. Patients are often reluctant to discuss these therapies with their oncologist, and oncologists may have limited knowledge
Externí odkaz:
https://doaj.org/article/d05e87d28da6492692e61b57957cb143
Autor:
Safiya Karim, William J. Mackillop, Kelly Brennan, Yingwei Peng, D. Robert Siemens, Monika K. Krzyzanowska, Christopher M. Booth
Publikováno v:
Cancer Medicine, Vol 8, Iss 14, Pp 6258-6271 (2019)
Abstract Background Identifying optimal chemotherapy (CT) utilization rates can drive improvements in quality of care. We report a benchmarking approach to estimate the optimal rate of perioperative CT for muscle‐invasive bladder cancer (MIBC). Met
Externí odkaz:
https://doaj.org/article/f39e9b91ca7d445e8bb476573d2e4ccb